Use access key #2 to skip to page content.
$0.64 0.04 (6.67%)
10/7/2008 11:10 AM

Cell Genesys, Inc. (CEGE)

CAPS Rating:
****

A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.

View All Commentary (CEGE)

Recs

3

Avatar ctmedic00 (99.97) Submitted: 1/26/07 1:09 PM : Outperform Start Price: $3.23 CEGE Score: -53.50

I heard one of their subsidaries CEOs giving an interview and was very interested in hearing about the DNA sequencing and the value that is returning. If he is correct and, I don't know either way, this is a great speculative bet. Anything involving DNA is a great long speculation and terrible short because any news, rumor or just nonsense can send this stock into the stratosphere. I'm optimistic and probably irrationally so but hey why not?

Report this Post Replies: 1 | Reply

Avatar lquadland10 (< 20) Submitted: 4/16/07 8:49 PM

Recs: 0 | Rec This

JUST LOOKS GOOD TO ME BUT I HAVE BEEN WRONG BEFORE.

Report this Post Reply

Featured Broker Partners